Study finds outcomes for lung conditions worse at private equity-owned hospitals
· Medical Xpressedited by Sadie Harley, reviewed by Andrew Zinin
Sadie Harley
Scientific Editor
Meet our editorial team
Behind our editorial process
Andrew Zinin
Lead Editor
Meet our editorial team
Behind our editorial process Editors' notes
This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:
fact-checked
trusted source
proofread
The GIST Add as preferred source
A large study presented at the 2026 ATS International Conference shows that patients treated for COPD or pneumonia experience worse outcomes across several important measures when they are treated at hospitals that have been acquired by private equity firms.
Notably, patients with pneumonia are more likely to die during their stay in hospitals that have been acquired by private equity than in other hospitals. At the same time, patients with COPD are more likely to revisit the hospital within the first 30 days compared to patients at other hospitals.
This is the first study to show that private equity acquisition is linked to worse outcomes for patients with these pulmonary conditions.
"Our findings add to growing concerns around the detrimental effects of private equity in health care and highlight a critical need for stronger regulations of these acquisitions to protect our patients," said first author Stephen Mein, MD, a pulmonologist at Beth Israel Deaconess Medical Center and researcher at the Richard A. and Susan F. Smith Center for Outcomes Research in Boston.
The number of U.S. hospitals acquired by private equity firms is rapidly increasing. Previous studies have shown that when hospitals are acquired by private equity firms, patients report worse experiences with care and have higher rates of hospital-acquired adverse events like falls and bloodstream infections.
However, few studies have examined how private equity acquisition impacts specific diseases, including COPD and pneumonia—the most common lung-related reasons for hospital admission.
For the study, researchers analyzed data from more than 146,900 COPD and 194,900 pneumonia encounters at private-equity hospitals. They matched the private equity hospitals with a control group of hospitals not owned by private equity firms, and compared outcomes among patients hospitalized at two groups of hospitals.
Patients with COPD saw a 1-percentage-point increase. Deaths among pneumonia patients increased by almost 1 percentage point.
"The rise in deaths among patients hospitalized with pneumonia is especially concerning," Dr. Mein said. "While a 1-percentage-point increase may sound small, it represents a substantial change when the typical in-hospital mortality rate for patients with pneumonia is only 3% to 4%."
Dr. Mein noted that private equity firms are incentivized to generate profits over short time periods, a goal that may not always align with delivering high-quality care.
More information
C16 – Markets and Mandates: Health Policy and Pulmonary Outcomes; Clinical Outcomes for Pulmonary Conditions Worsened After Private Equity Acquisition of U.S. Hospitals
Key medical concepts
COPDPneumoniaLung DiseasesBlood Poisonings
Clinical categories
Pulmonary medicineHospital medicineCommon illnesses & Prevention Provided by American Thoracic Society Who's behind this story?
Sadie Harley
BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →
Andrew Zinin
Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →
Citation: Study finds outcomes for lung conditions worse at private equity-owned hospitals (2026, May 19) retrieved 19 May 2026 from https://medicalxpress.com/news/2026-05-outcomes-lung-conditions-worse-private.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.